{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T04:15:30Z","timestamp":1728360930613},"reference-count":12,"publisher":"Aerospace Medical Association","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["aerosp med hum perform"],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold> Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multisystem involvement. Clinical management of this condition has unique aeromedical considerations and an impact on subsequent aeromedical disposition. A comprehensive decision matrix\n would greatly benefit aviation medicine practitioners in the management of aircrew and personnel in flying-related vocations who are diagnosed with SLE.<jats:bold>CASE REPORT:<\/jats:bold> We describe the aeromedical management of a military air traffic controller who was diagnosed with SLE after presenting\n with cutaneous lupus, nonscarring alopecia, symmetrical small joint polyarthropathy, leukopenia, and presence of SLE-specific antibody. She was treated with hydroxychloroquine and low-dose systemic glucocorticoids, and allowed to return to duties with a proximity restriction and a bar on field\n deployments and night duties.<jats:bold>DISCUSSION:<\/jats:bold> Several SLE manifestations may have either incapacitating or distracting effects on aircrew and personnel in flying-related vocations. Some medications used in the treatment of SLE may similarly impact on an individuals ability to safely\n execute flight or air traffic control duties. We propose an aeromedical disposition decision flowchart that would guide aviation medicine practitioners in the management of individuals diagnosed with SLE to ensure optimal and safe performance in their respective occupational settings.<jats:bold>Seah\n BZQ, Chua CG. <jats:italic>A proposed aeromedical disposition flowchart for systemic lupus erythematosus<\/jats:italic>. Aerosp Med Hum Perform. 2020; 91(10):826832.<\/jats:bold><\/jats:p>","DOI":"10.3357\/amhp.5684.2020","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T04:40:02Z","timestamp":1601354402000},"page":"826-832","source":"Crossref","is-referenced-by-count":0,"title":["A Proposed Aeromedical Disposition Flowchart for Systemic Lupus Erythematosus"],"prefix":"10.3357","volume":"91","author":[{"given":"Benjamin Zhi","family":"Qiang Seah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Choon Guan","family":"Chua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1911","reference":[{"issue":"2","key":"bib1","first-page":"306","article-title":"Quality of life in systemic lupus erythematosus: a controlled study","volume":"26","author":"Abu-Shakra","year":"1999","journal-title":"J Rheumatol."},{"issue":"7","key":"bib2","first-page":"1265","article-title":"Mortality studies in systemic lupus erythematosus. Results from a single centre. II. Predictor variables for mortality","volume":"22","author":"Abu-Shakra","year":"1995","journal-title":"J Rheumatol."},{"issue":"2","key":"bib3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/art.38210","article-title":"Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis","volume":"66","author":"del Rincn","year":"2014","journal-title":"Arthritis Rheumatol."},{"issue":"5","key":"bib4","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/BOR.0b013e328356d2f5","article-title":"FRAX updates 2012","volume":"24","author":"McCloskey","year":"2012","journal-title":"Curr Opin Rheumatol."},{"issue":"12","key":"bib5","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/jamaophthalmol.2014.3459","article-title":"The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy","volume":"132","author":"Melles","year":"2014","journal-title":"JAMA Ophthalmol."},{"issue":"1","key":"bib6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0021-9681(55)90018-7","article-title":"Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus","volume":"1","author":"Merrell","year":"1955","journal-title":"J Chronic Dis."},{"issue":"5","key":"bib7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/ard.61.5.409","article-title":"Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades","volume":"61","author":"Moss","year":"2002","journal-title":"Ann Rheum Dis."},{"issue":"4","key":"bib8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.semarthrit.2008.10.007","article-title":"Understanding the epidemiology and progression of systemic lupus erythematosus","volume":"39","author":"Pons-Estel","year":"2010","journal-title":"Semin Arthritis Rheum."},{"issue":"4","key":"bib9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1177\/096120339500400407","article-title":"Factors associated with mood and mood disorders in SLE","volume":"4","author":"Shortall","year":"1995","journal-title":"Lupus."},{"issue":"6","key":"bib10","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/clinids\/11.6.954","article-title":"Risk of infectious complications in patients taking glucocorticosteroids","volume":"11","author":"Stuck","year":"1989","journal-title":"Rev Infect Dis."},{"issue":"2","key":"bib11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0002-9343(76)90431-9","article-title":"The bimodal mortality pattern of systemic lupus erythematosus","volume":"60","author":"Urowitz","year":"1976","journal-title":"Am J Med."},{"issue":"6","key":"bib12","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1080\/030097498442226","article-title":"Emotional status in systemic lupus erythematosus","volume":"27","author":"Waterloo","year":"1998","journal-title":"Scand J Rheumatol."}],"container-title":["Aerospace Medicine and Human Performance"],"original-title":[],"link":[{"URL":"https:\/\/asma.kglmeridian.com\/view\/journals\/amhp\/91\/10\/article-p826.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/asma.kglmeridian.com\/downloadpdf\/journals\/amhp\/91\/10\/article-p826.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/asma.kglmeridian.com\/downloadpdf\/journals\/amhp\/91\/10\/article-p826.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T12:25:17Z","timestamp":1728303917000},"score":1,"resource":{"primary":{"URL":"https:\/\/asma.kglmeridian.com\/view\/journals\/amhp\/91\/10\/article-p826.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":12,"journal-issue":{"issue":"10"},"URL":"https:\/\/doi.org\/10.3357\/amhp.5684.2020","relation":{},"ISSN":["2375-6314","2375-6322"],"issn-type":[{"type":"print","value":"2375-6314"},{"type":"electronic","value":"2375-6322"}],"subject":[],"published":{"date-parts":[[2020,10,1]]}}}